| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Sep 08, 2026 |
Summit Therapeutics Inc
SMMT
|
BUY |
$33.00
Est. +91%
|
$17.27 | $19.07 |
Pending
|
$15.57
-9.8%
|
| Aug 21, 2026 |
Syndax Pharmaceuticals Inc
SNDX
|
BUY |
$33.00
Est. +67%
|
$19.75 | $21.00 |
Pending
|
$13.09
-33.7%
|
| Aug 20, 2026 |
Iovance Biotherapeutics Inc
IOVA
|
SELL |
$7.00
Est. +12%
|
$7.99 | $7.66 (Low) |
Pending
|
$14.21
-77.8%
|
| Aug 17, 2026 |
Cullinan Therapeutics Inc
CGEM
|
BUY |
$27.00
Est. +30%
|
$20.76 | $23.19 |
Pending
|
$13.98
-32.7%
|
| Jun 10, 2026 |
Nuvalent Inc - Ordinary Shares - Class A
NUVL
|
BUY |
$124.00
Est. +1%
|
$123.25 | $123.99 |
Bullseye Hit (±1%)
|
$123.96
+0.6%
|
| Jun 09, 2026 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$23.00
Est. +53%
|
$15.07 | $27.50 |
Target Met
|
$24.93
+65.4%
|
| Mar 13, 2026 |
Kura Oncology Inc
KURA
|
BUY |
$15.00
Est. +74%
|
$8.60 | $13.90 |
Pending
|
$9.36
+8.8%
|
| Dec 02, 2025 |
Janux Therapeutics Inc
JANX
|
BUY |
$57.00
Est. +230%
|
$17.28 | $20.31 |
Pending
|
$16.74
-3.1%
|
| Oct 31, 2025 |
Nuvalent Inc - Ordinary Shares - Class A
NUVL
|
BUY |
$132.00
Est. +34%
|
$98.17 | $123.99 |
Pending
|
$123.96
+26.3%
|
| Jul 15, 2025 |
Syndax Pharmaceuticals Inc
SNDX
|
BUY |
$35.00
Est. +257%
|
$9.80 | $25.58 |
Miss
|
$13.09
+33.6%
|
| May 16, 2025 |
Iovance Biotherapeutics Inc
IOVA
|
BUY |
$2.00
Est. +20%
|
$1.66 | $5.63 |
Target Met
|
$14.21
+756.0%
|
| Oct 24, 2024 |
Iovance Biotherapeutics Inc
IOVA
|
BUY |
$17.00
Est. +73%
|
$9.82 | $12.50 |
Miss
|
$14.21
+44.7%
|
| Oct 24, 2024 |
Janux Therapeutics Inc
JANX
|
BUY |
$69.00
Est. +33%
|
$51.75 | $71.71 |
Target Met
|
$16.74
-67.7%
|
| Oct 24, 2024 |
Kura Oncology Inc
KURA
|
BUY |
$27.00
Est. +59%
|
$17.02 | $19.73 |
Miss
|
$9.36
-45.0%
|
| Oct 24, 2024 |
Perspective Therapeutics Inc
CATX
|
BUY |
$20.00
Est. +71%
|
$11.69 | $12.90 |
Miss
|
$2.19
-81.3%
|
| Oct 24, 2024 |
Syndax Pharmaceuticals Inc
SNDX
|
BUY |
$37.00
Est. +100%
|
$18.54 | $22.50 |
Miss
|
$13.09
-29.4%
|
| Oct 24, 2024 |
Nuvalent Inc - Ordinary Shares - Class A
NUVL
|
BUY |
$100.00
Est. +7%
|
$93.71 | $99.94 |
Bullseye Hit (±1%)
|
$123.96
+32.3%
|
| Oct 24, 2024 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$35.00
Est. +41%
|
$24.78 | $29.56 |
Miss
|
$24.93
+0.6%
|
| Oct 24, 2024 |
Cullinan Therapeutics Inc
CGEM
|
BUY |
$30.00
Est. +92%
|
$15.61 | $17.50 |
Miss
|
$13.98
-10.4%
|
| Oct 24, 2024 |
Ideaya Biosciences Inc
IDYA
|
BUY |
$50.00
Est. +69%
|
$29.50 | $32.67 |
Miss
|
$33.81
+14.6%
|
| Oct 24, 2024 |
Cg Oncology Inc.
CGON
|
BUY |
$60.00
Est. +68%
|
$35.61 | $45.56 |
Miss
|
$59.96
+68.4%
|
| Oct 24, 2024 |
Immunocore Holdings plc - ADR
IMCR
|
SELL |
$24.00
Est. +25%
|
$32.02 | $23.15 (Low) |
Target Met
|
$29.84
+6.8%
|
| Oct 24, 2024 |
Merus N.V
MRUS
|
BUY |
$72.00
Est. +38%
|
$52.31 | $95.06 |
Target Met
|
$90.00
+72.1%
|
| Oct 24, 2024 |
Blueprint Medicines Corp
BPMC
|
BUY |
$88.00
Est. +4%
|
$84.40 | $129.65 |
Target Met
|
$129.46
+53.4%
|